With investors perched on the edge of their seats for months, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) announces a deal including upfront milestones and partner-funded asset development. On ...
The company will receive an upfront payment of $10 million. It could also earn up to $75 million in development milestones, $100 million in sales milestones, and single-digit royalties on future ...
Some songs make you move. Others make you stop. In the enigmatic landscape of contemporary Punjabi music, where rhythms often blaze and lyrics exude bravado, Ansh Chahal’s latest release “Raat Di Rani ...
Hosted on MSN
H.C. Wainwright Initiates Rani Therapeutics (RANI) with Buy and $11 PT on RaniPill Potential
Rani Therapeutics Holdings Inc. (NASDAQ:RANI) is one of the hot stocks to buy with huge upside potential. On October 21, H.C. Wainwright analyst Brandon Folkes assumed coverage of Rani Therapeutics ...
The average one-year price target for Rani Therapeutics Holdings (NasdaqGM:RANI) has been revised to $10.71 / share. This is an increase of 20.00% from the prior estimate of $8.92 dated September 27, ...
South Cone Investments Limited Partnership, a ten percent owner of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), sold 5,923,000 shares of Class A Common Stock on October 20 and 21, 2025, for a total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback